Related Experiment Video

Updated: Jun 21, 2026

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

Age-related macular degeneration: experimental and emerging treatments

Jean Pierre Hubschman1, Shantan Reddy, Steven D Schwartz

  • 1Jules Stein Eye Institute, Department of Ophthalmology, University of California, David Geffen School of Medicine, Los Angeles, California, USA.

Clinical Ophthalmology (Auckland, N.Z.)
|August 12, 2009
PubMed
Abstract

Insights

New treatments for age-related macular degeneration (AMD) focus on blocking vascular endothelial growth factor (VEGF) and targeting inflammation. Advanced imaging aids in early detection and precise treatment monitoring for better visual outcomes.

Area of Science:

  • Ophthalmology
  • Regenerative Medicine
  • Medical Imaging

Background:

  • Age-related macular degeneration (AMD) is a leading cause of vision loss.
  • Current treatments for AMD have limitations in efficacy and patient outcomes.

Purpose of the Study:

  • To review experimental treatments for exudative and non-exudative AMD.
  • To explore the role of novel imaging modalities in AMD management.

Main Methods:

  • Interpretative essay based on a literature review.
  • Analysis of current research on AMD therapeutic strategies.

Main Results:

  • Exudative AMD treatments include anti-VEGF therapies and tyrosine kinase inhibitors.
  • Non-exudative AMD treatments target inflammation, oxidative stress, and immune modulation.
  • Enhanced imaging improves early disease detection and treatment response monitoring.

Conclusions:

  • Advances in understanding AMD at the genetic and molecular level are crucial.
  • Improved imaging modalities combined with targeted therapies offer potential for significant visual gains and reduced treatment burden.
Keywords:
PEDFSiRNAVEGFage-related macular degeneration

More Related Videos

LipidUNet-Machine Learning-Based Method of Characterization and Quantification of Lipid Deposits Using iPSC-Derived Retinal Pigment Epithelium06:16

LipidUNet-Machine Learning-Based Method of Characterization and Quantification of Lipid Deposits Using iPSC-Derived Retinal Pigment Epithelium

Published on: July 28, 2023

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System07:04

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System

Published on: February 4, 2021

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...